Abstract | BACKGROUND: METHODS: Eight cases from 5 DILIN centers were reviewed for clinical course, laboratory values, imaging, and histopathology. RESULTS: Seven females, aged 29-59 years, and one 8-year-old boy, all with leukemia, developed jaundice within 9-21 days (median 15 days) of starting asparaginase or pegaspargase, during the first (n = 6) or second (n = 2) cycle. Prominent symptoms were jaundice (n = 8), fatigue (6), abdominal pain (6) but rarely pruritus (1). Initial median ALT level was 284 U/L (range 83-1076), Alk P 159 U/L (64-452), and bilirubin 4.4 mg/dL (3.7-8.4). Bilirubin levels rose thereafter in all patients to median peak of 17.5 mg/dL (11.7-25.7), INR rose to 1.1-1.7 and serum albumin fell to 1.5-2.6 g/dL. Hepatic imaging revealed fatty liver in all patients. Liver biopsy showed steatosis but minimal hepatocyte necrosis. One patient restarted on pegaspargase re-developed less severe injury. CONCLUSION:
|
Authors | Natasha Kamal, Christopher Koh, Niharika Samala, Robert J Fontana, Andrew Stolz, Francisco Durazo, Paul H Hayashi, Elizabeth Phillips, Tongrong Wang, Jay H Hoofnagle, Drug-Induced Liver Injury Network |
Journal | Hepatology international
(Hepatol Int)
Vol. 13
Issue 5
Pg. 641-648
(Sep 2019)
ISSN: 1936-0541 [Electronic] United States |
PMID | 31392570
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Polyethylene Glycols
- pegaspargase
- Asparaginase
- Bilirubin
|
Topics |
- Adult
- Antineoplastic Agents
(therapeutic use, toxicity)
- Asparaginase
(therapeutic use, toxicity)
- Bilirubin
(blood)
- Chemical and Drug Induced Liver Injury
(etiology)
- Cholestasis
(chemically induced)
- Fatty Liver
(chemically induced)
- Female
- Humans
- Liver
(drug effects, pathology)
- Male
- Middle Aged
- Polyethylene Glycols
(therapeutic use, toxicity)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy)
|